Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Health https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Indiana Coronavirus Updates for October 14, 2020

Indiana Coronavirus Updates for October 14, 2020



Coronavirus updates from Wednesday, October 14.

INDIANAPOLIS – the latest updates on Wednesday for the coronavirus pandemic.

Hospitals are preparing to jump in cases of COVID-19 and influenza

Eskenazi Health and other hospitals are preparing for what could be the perfect storm: An increase in COVID-19 cases as the flu season begins at a high speed.

“We̵

7;ve dealt with the flu every year, but we’ve never had to deal with the flu on the coronavirus,” said Dr. Graham Carlos, chief of internal medicine at Eskenazi. “So the presence of two viruses that can affect the respiratory system is a cause for concern.”

Only the flu season is challenging for hospitals.

“Every year we have the flu season, we get stressed. There’s a lot of waiting in the emergency room for rooms. If we see COVID and the flu hit twice, it would certainly disrupt elective care,” said Christopher Doering, vice president of medical affairs at St. Louis Health. Francis.

With similar flu and coronavirus symptoms (fever, cough, fatigue and sore throat), hospitals will test both, while urging everyone to be active by getting a flu shot.

“We think that if the flu vaccine is widely used, it will simplify things for us, as the flu is starting to appear in the battle with COVID,” Doehring said.

Some hospitals have already noticed a jump. Last week, the IU Health Ball Memorial Hospital, Muncie, reported a “record record” in COVID-19 cases.

The latest American, world numbers

There are more than 7.85 million confirmed cases of COVID-19 in the United States at 3:30 a.m. Wednesday, according to Johns Hopkins University. There have been more than 215,000 deaths and 3.12 million people have recovered.

Globally, there are 38.13 million confirmed cases with over 1.08 million deaths and 26.47 million recoveries.

RELATED: See where Indiana coronavirus cases have been confirmed with this interactive map

RELATED: VERIFICATION: No, the CDC did not say that the number of COVID-19 victims who actually died from the virus was much smaller than originally reported.

The actual number of people infected with the virus worldwide is thought to be much higher – perhaps 10 times higher in the United States, according to the Centers for Disease Control and Prevention – given the limitations of testing and the many mild cases that not reported or unrecognized.

For most people, the coronavirus causes mild or moderate symptoms. For some, especially the elderly and people with pre-existing health problems, this can cause more serious illnesses such as pneumonia or death.

Chicago adds Indiana to the road order for COVID-19

The city of Chicago issued a health order Tuesday that will require people coming from Indiana to Chicago for non-working purposes and Chicago residents returning from Indiana for a 14-day quarantine.

People who travel to Indiana, albeit for less than 24 hours, should still be quarantined upon their return unless they are considered a significant worker or are students traveling to school.

Other states added to Tuesday’s emergency order include North Carolina, Rhode Island, New Mexico and Wisconsin.

The 14-day travel quarantine order begins on Friday, October 16th.

Eli Lilly pauses study to treat antibodies to COVID-19 due to possible safety issue

Eli Lilly confirmed that his study of the antiviral drug COVID-19 remdezivir plus experimental antibody therapy was paused “due to a lot of caution” and said safety was his main concern.

The company would not say more about what led to this step.

RELATED: Johnson & Johnson pauses COVID-19 vaccine due to “unexplained disease”

RELATED: A Trump official says the coronavirus vaccine is expected to begin in January

This study tested an antibody that Lily was developing with the Canadian company AbCellera. Trump received an experimental two-antibody combination drug from Regeneron Pharmaceuticals Inc.

Lilly and Regeneron have asked the US Food and Drug Administration to authorize the emergency use of their COVID-19 drugs while the late-stage studies continue.


Source link